Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Muhammad Shahab

Showing results (81-90 of 109) with videos related to

Pageof 11
Sort By:
Journal of Cellular and Molecular Medicine|April 18, 2024
A robust computational quest: Discovering potential hits to improve the treatment of pyrazinamide-resistant Mycobacterium tuberculosisMuhammad Shahab, Gabriel Christian de Farias Morais, Shopnil Akash, et al.
Human Mutation|April 20, 2026
Delving Into the Depths of <i>AGTR2</i>: In Silico Identification of Deleterious Nonsynonymous SNPs Associated With Cardiovascular DiseasesMuhammad Waleed Iqbal, Muhammad Shahab, Xinxiao Sun, et al.
Human Mutation|April 13, 2026
Engineering of the Melanoma Inhibitor of Apoptosis (ML-IAP) Anticancer Peptide Through Comprehensive In Silico ApproachesHaitham Ahmed Al-Madhagi, Muhammad Shahab, Zheng Guojun, et al.
The Journal of Allergy and Clinical Immunology|March 31, 2012
Antiviral IFN-γ responses of monocytes at birth predict respiratory tract illness in the first year of lifeKaharu Sumino, Jennifer Tucker, Muhammad Shahab, et al.
Scientific Reports|January 13, 2025
Integrating machine learning and structure-based approaches for repurposing potent tyrosine protein kinase Src inhibitors to treat inflammatory disordersMuhammad Waleed Iqbal, Muhammad Shahab, Zakir Ullah, et al.
Scientific Reports|June 7, 2024
In silico design of peptide inhibitors for Dengue virus to treat Dengue virus-associated infectionsAmar Ajmal, Muhammad Shahab, Muhammad Waqas, et al.
ACS Omega|January 22, 2024
Exploring <i>Citrus sinensis</i> Phytochemicals as Potential Inhibitors for Breast Cancer Genes BRCA1 and BRCA2 Using Pharmacophore Modeling, Molecular Docking, MD Simulations, and DFT AnalysisMehreen Zia, Shagufta Parveen, Nusrat Shafiq, et al.
Scientific Reports|May 17, 2024
Molecular modeling and simulation approaches to characterize potential molecular targets for burdock inulin to instigate protection against autoimmune diseasesHuma Farooque Hashmi, Xu Xuan, Kaoshan Chen, et al.
Journal of Biomolecular Structure & Dynamics|January 31, 2024
<i>In silico</i> exploration of the potential inhibitory activities of in-house and ZINC database lead compounds against alpha-glucosidase using structure-based virtual screening and molecular dynamics simulation approachZuhier A Awan, Haider Ali Khan, Alam Jamal, et al.
RSC Advances|June 10, 2026
Synergistic theoretical and electrochemical evaluation of sulfonamide-based inhibitors for mild steel corrosion in HClSoukaina Alaoui Mrani, Dounia Azzouni, Chahrazad El Abiad, et al.
Pageof 11

Showing results (81-90 of 109) with videos related to

Sort By:
Pageof 11
Journal of Cellular and Molecular Medicine|April 18, 2024
A robust computational quest: Discovering potential hits to improve the treatment of pyrazinamide-resistant Mycobacterium tuberculosisMuhammad Shahab, Gabriel Christian de Farias Morais, Shopnil Akash, et al.
Human Mutation|April 20, 2026
Delving Into the Depths of <i>AGTR2</i>: In Silico Identification of Deleterious Nonsynonymous SNPs Associated With Cardiovascular DiseasesMuhammad Waleed Iqbal, Muhammad Shahab, Xinxiao Sun, et al.
Human Mutation|April 13, 2026
Engineering of the Melanoma Inhibitor of Apoptosis (ML-IAP) Anticancer Peptide Through Comprehensive In Silico ApproachesHaitham Ahmed Al-Madhagi, Muhammad Shahab, Zheng Guojun, et al.
The Journal of Allergy and Clinical Immunology|March 31, 2012
Antiviral IFN-γ responses of monocytes at birth predict respiratory tract illness in the first year of lifeKaharu Sumino, Jennifer Tucker, Muhammad Shahab, et al.
Scientific Reports|January 13, 2025
Integrating machine learning and structure-based approaches for repurposing potent tyrosine protein kinase Src inhibitors to treat inflammatory disordersMuhammad Waleed Iqbal, Muhammad Shahab, Zakir Ullah, et al.
Scientific Reports|June 7, 2024
In silico design of peptide inhibitors for Dengue virus to treat Dengue virus-associated infectionsAmar Ajmal, Muhammad Shahab, Muhammad Waqas, et al.
ACS Omega|January 22, 2024
Exploring <i>Citrus sinensis</i> Phytochemicals as Potential Inhibitors for Breast Cancer Genes BRCA1 and BRCA2 Using Pharmacophore Modeling, Molecular Docking, MD Simulations, and DFT AnalysisMehreen Zia, Shagufta Parveen, Nusrat Shafiq, et al.
Scientific Reports|May 17, 2024
Molecular modeling and simulation approaches to characterize potential molecular targets for burdock inulin to instigate protection against autoimmune diseasesHuma Farooque Hashmi, Xu Xuan, Kaoshan Chen, et al.
Journal of Biomolecular Structure & Dynamics|January 31, 2024
<i>In silico</i> exploration of the potential inhibitory activities of in-house and ZINC database lead compounds against alpha-glucosidase using structure-based virtual screening and molecular dynamics simulation approachZuhier A Awan, Haider Ali Khan, Alam Jamal, et al.
RSC Advances|June 10, 2026
Synergistic theoretical and electrochemical evaluation of sulfonamide-based inhibitors for mild steel corrosion in HClSoukaina Alaoui Mrani, Dounia Azzouni, Chahrazad El Abiad, et al.
Pageof 11